Variable expression of soluble fms-like tyrosine kinase 1 in patients at high risk for preeclampsia

Bonnie K. Dwyer, Sacha Krieg, Raymond Balise, Ian R. Carroll, Jane Chueh, Nihar Nayak, Maurice Druzin

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective.To explore angiogenic factor differences in preeclamptic patients according to the absence or presence of underlying vascular disease. Methods.We prospectively compared serum soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor (PlGF) from 41 normal-risk and 32 high-risk (preexisting conditions) subjects at serial gestational ages. Results.Median sFlt1 was lower at delivery in preeclamptic patients with underlying chronic hypertension and/or chronic proteinuria (5115pg/ml) compared with normal risk preeclamptic patients (16375pg/ml). PlGF was consistently low in patients who developed preeclampsia. Conclusions.Effects of sFlt1 may be contextual, varying according to the health or disease state of vascular endothelium.

Original languageEnglish (US)
Pages (from-to)705-711
Number of pages7
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume23
Issue number7
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Vascular Endothelial Growth Factor Receptor-1
Pre-Eclampsia
Intercellular Signaling Peptides and Proteins
Preexisting Condition Coverage
Angiogenesis Inducing Agents
Vascular Endothelium
Vascular Diseases
Proteinuria
Gestational Age
Hypertension
Health
Serum

Keywords

  • High risk pregnancy
  • Hypertension
  • Placental growth factor
  • Preeclampsia
  • Proteinuria
  • Soluble endoglin
  • Soluble fms-like tyrosine kinase 1

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology
  • Medicine(all)

Cite this

Variable expression of soluble fms-like tyrosine kinase 1 in patients at high risk for preeclampsia. / Dwyer, Bonnie K.; Krieg, Sacha; Balise, Raymond; Carroll, Ian R.; Chueh, Jane; Nayak, Nihar; Druzin, Maurice.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 23, No. 7, 2010, p. 705-711.

Research output: Contribution to journalArticle

Dwyer, Bonnie K. ; Krieg, Sacha ; Balise, Raymond ; Carroll, Ian R. ; Chueh, Jane ; Nayak, Nihar ; Druzin, Maurice. / Variable expression of soluble fms-like tyrosine kinase 1 in patients at high risk for preeclampsia. In: Journal of Maternal-Fetal and Neonatal Medicine. 2010 ; Vol. 23, No. 7. pp. 705-711.
@article{33bf3e17d8aa4b288ed822f288c8f894,
title = "Variable expression of soluble fms-like tyrosine kinase 1 in patients at high risk for preeclampsia",
abstract = "Objective.To explore angiogenic factor differences in preeclamptic patients according to the absence or presence of underlying vascular disease. Methods.We prospectively compared serum soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor (PlGF) from 41 normal-risk and 32 high-risk (preexisting conditions) subjects at serial gestational ages. Results.Median sFlt1 was lower at delivery in preeclamptic patients with underlying chronic hypertension and/or chronic proteinuria (5115pg/ml) compared with normal risk preeclamptic patients (16375pg/ml). PlGF was consistently low in patients who developed preeclampsia. Conclusions.Effects of sFlt1 may be contextual, varying according to the health or disease state of vascular endothelium.",
keywords = "High risk pregnancy, Hypertension, Placental growth factor, Preeclampsia, Proteinuria, Soluble endoglin, Soluble fms-like tyrosine kinase 1",
author = "Dwyer, {Bonnie K.} and Sacha Krieg and Raymond Balise and Carroll, {Ian R.} and Jane Chueh and Nihar Nayak and Maurice Druzin",
year = "2010",
doi = "10.3109/14767050903258753",
language = "English (US)",
volume = "23",
pages = "705--711",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Variable expression of soluble fms-like tyrosine kinase 1 in patients at high risk for preeclampsia

AU - Dwyer, Bonnie K.

AU - Krieg, Sacha

AU - Balise, Raymond

AU - Carroll, Ian R.

AU - Chueh, Jane

AU - Nayak, Nihar

AU - Druzin, Maurice

PY - 2010

Y1 - 2010

N2 - Objective.To explore angiogenic factor differences in preeclamptic patients according to the absence or presence of underlying vascular disease. Methods.We prospectively compared serum soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor (PlGF) from 41 normal-risk and 32 high-risk (preexisting conditions) subjects at serial gestational ages. Results.Median sFlt1 was lower at delivery in preeclamptic patients with underlying chronic hypertension and/or chronic proteinuria (5115pg/ml) compared with normal risk preeclamptic patients (16375pg/ml). PlGF was consistently low in patients who developed preeclampsia. Conclusions.Effects of sFlt1 may be contextual, varying according to the health or disease state of vascular endothelium.

AB - Objective.To explore angiogenic factor differences in preeclamptic patients according to the absence or presence of underlying vascular disease. Methods.We prospectively compared serum soluble fms-like tyrosine kinase 1 (sFlt1), soluble endoglin, and placental growth factor (PlGF) from 41 normal-risk and 32 high-risk (preexisting conditions) subjects at serial gestational ages. Results.Median sFlt1 was lower at delivery in preeclamptic patients with underlying chronic hypertension and/or chronic proteinuria (5115pg/ml) compared with normal risk preeclamptic patients (16375pg/ml). PlGF was consistently low in patients who developed preeclampsia. Conclusions.Effects of sFlt1 may be contextual, varying according to the health or disease state of vascular endothelium.

KW - High risk pregnancy

KW - Hypertension

KW - Placental growth factor

KW - Preeclampsia

KW - Proteinuria

KW - Soluble endoglin

KW - Soluble fms-like tyrosine kinase 1

UR - http://www.scopus.com/inward/record.url?scp=77953634402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953634402&partnerID=8YFLogxK

U2 - 10.3109/14767050903258753

DO - 10.3109/14767050903258753

M3 - Article

C2 - 19895348

AN - SCOPUS:77953634402

VL - 23

SP - 705

EP - 711

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 7

ER -